Conclusion: This study emphasizes the role of elevated pro-inflammatory cytokines (IL-6 and TNF-α) and antiphospholipid antibodies in RPL among people with hereditary thrombophilia. This evidence concerns the gene TNF and Rare hereditary thrombophilia.